Shaukat A, Zaidi A, Anwar H, Kizilbash N
Front Nutr. 2023; 10:1126272.
PMID: 37818339
PMC: 10561288.
DOI: 10.3389/fnut.2023.1126272.
Minsart C, Rorive S, Lemmers A, Quertinmont E, Gustot T
World J Hepatol. 2020; 12(9):596-618.
PMID: 33033567
PMC: 7522565.
DOI: 10.4254/wjh.v12.i9.596.
Yarema M, Chopra P, Sivilotti M, Johnson D, Nettel-Aguirre A, Bailey B
J Med Toxicol. 2018; 14(2):120-127.
PMID: 29423816
PMC: 5962465.
DOI: 10.1007/s13181-018-0653-9.
Nabi T, Nabi S, Rafiq N, Shah A
Saudi J Gastroenterol. 2017; 23(3):169-175.
PMID: 28611340
PMC: 5470376.
DOI: 10.4103/1319-3767.207711.
Zyoud S, Waring W, Al-Jabi S, Sweileh W, Awang R
Springerplus. 2016; 5(1):1534.
PMID: 27652107
PMC: 5019997.
DOI: 10.1186/s40064-016-3240-z.
N-acetylcysteine overdose after acetaminophen poisoning.
Mahmoudi G, Astaraki P, Zafar Mohtashami A, Ahadi M
Int Med Case Rep J. 2015; 8:65-9.
PMID: 25767408
PMC: 4354467.
DOI: 10.2147/IMCRJ.S74563.
Reported ingested dose of paracetamol as a predictor of risk following paracetamol overdose.
Leang Y, Taylor D, Dargan P, Wood D, Greene S
Eur J Clin Pharmacol. 2014; 70(12):1513-8.
PMID: 25270975
DOI: 10.1007/s00228-014-1756-0.
Recent updates on acetaminophen hepatotoxicity: the role of nrf2 in hepatoprotection.
Gum S, Cho M
Toxicol Res. 2014; 29(3):165-72.
PMID: 24386516
PMC: 3877995.
DOI: 10.5487/TR.2013.29.3.165.
The amelioration of N-acetyl-p-benzoquinone imine toxicity by ginsenoside Rg3: the role of Nrf2-mediated detoxification and Mrp1/Mrp3 transports.
Gum S, Cho M
Oxid Med Cell Longev. 2013; 2013:957947.
PMID: 23766864
PMC: 3666202.
DOI: 10.1155/2013/957947.
Pharmacokinetics of intravenous N-acetylcysteine in men at rest and during exercise.
Brown M, Bjorksten A, Medved I, McKenna M
Eur J Clin Pharmacol. 2004; 60(10):717-23.
PMID: 15619135
DOI: 10.1007/s00228-004-0862-9.
Should a lower treatment line be used when treating paracetamol poisoning in patients with chronic alcoholism?: a case against.
Dargan P, Jones A
Drug Saf. 2002; 25(9):625-32.
PMID: 12137557
DOI: 10.2165/00002018-200225090-00002.
Paracetamol overdose: an evidence based flowchart to guide management.
Wallace C, Dargan P, Jones A
Emerg Med J. 2002; 19(3):202-5.
PMID: 11971827
PMC: 1725876.
DOI: 10.1136/emj.19.3.202.
Management of drug-induced liver disease.
Marino G, ZIMMERMAN H, Lewis J
Curr Gastroenterol Rep. 2001; 3(1):38-48.
PMID: 11177693
DOI: 10.1007/s11894-001-0039-y.
Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning.
Schmidt L, Dalhoff K
Br J Clin Pharmacol. 2001; 51(1):87-91.
PMID: 11167669
PMC: 2014432.
DOI: 10.1046/j.1365-2125.2001.01305.x.
Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi.
Henderson C, Wolf C, Kitteringham N, Powell H, Otto D, Park B
Proc Natl Acad Sci U S A. 2000; 97(23):12741-5.
PMID: 11058152
PMC: 18834.
DOI: 10.1073/pnas.220176997.
Management of self poisoning.
Jones A, Volans G
BMJ. 1999; 319(7222):1414-7.
PMID: 10574863
PMC: 1117144.
DOI: 10.1136/bmj.319.7222.1414.
N-acetylcysteine inhibits muscle fatigue in humans.
Reid M, Stokic D, Koch S, Khawli F, Leis A
J Clin Invest. 1994; 94(6):2468-74.
PMID: 7989604
PMC: 330079.
DOI: 10.1172/JCI117615.
Paracetamol poisoning in children and hepatotoxicity.
Penna A, Buchanan N
Br J Clin Pharmacol. 1991; 32(2):143-9.
PMID: 1931463
PMC: 1368435.
DOI: 10.1111/j.1365-2125.1991.tb03873.x.
